EISAI-E2020-J081-231

Study Sponsor: Eisai

Study Title

A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

Medicine or Vaccine (generic name)

donepezil

Sponsor Identification Number

E2020-J081-231

Trial Registry Identification Number(#'s)

NCT00165659

Medical Condition

Alzheimer's Disease

Phase

Phase 2

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

not available

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions.

Date Added to this Site

August 2019